High Point Advisor Group LLC Astrazeneca PLC Transaction History
High Point Advisor Group LLC
- $1.84 Billion
- Q2 2025
A detailed history of High Point Advisor Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, High Point Advisor Group LLC holds 26,827 shares of AZN stock, worth $2.25 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
26,827
Previous 24,111
11.26%
Holding current value
$2.25 Million
Previous $1.77 Million
5.76%
% of portfolio
0.1%
Previous 0.1%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
498MCall Options Held
7.11MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...